Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/109784
DC FieldValueLanguage
dc.contributor.authorRoss, Owen A.-
dc.contributor.authorSoto-Ortolaza, Alexandra I.-
dc.contributor.authorHeckman, Michael G.-
dc.contributor.authorVerbeeck, Christophe-
dc.contributor.authorSerie, Daniel J.-
dc.contributor.authorRayaprolu, Sruti-
dc.contributor.authorRich, Stephen S.-
dc.contributor.authorNalls, Michael A.-
dc.contributor.authorSingleton, Andrew-
dc.contributor.authorGuerreiro, Rita-
dc.contributor.authorKinsella, Emma-
dc.contributor.authorWszolek, Zbigniew K.-
dc.contributor.authorBrott, Thomas G.-
dc.contributor.authorBrown, Robert D.-
dc.contributor.authorWorrall, Bradford B.-
dc.contributor.authorMeschia, James F.-
dc.date.accessioned2023-10-26T10:22:59Z-
dc.date.available2023-10-26T10:22:59Z-
dc.date.issued2013-
dc.identifier.issn1932-6203pt
dc.identifier.urihttps://hdl.handle.net/10316/109784-
dc.description.abstractBackground: Mutations within the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). CADASIL mutations appear to be restricted to the first twenty-four exons, resulting in the gain or loss of a cysteine amino acid. The role of other exonic NOTCH3 variation not involving cysteine residues and mutations in exons 25-33 in ischemic stroke remains unresolved. Methods: All 33 exons of NOTCH3 were sequenced in 269 Caucasian probands from the Siblings With Ischemic Stroke Study (SWISS), a 70-center North American affected sibling pair study and 95 healthy Caucasian control subjects. Variants identified by sequencing in the SWISS probands were then tested for association with ischemic stroke using US Caucasian controls collected at the Mayo Clinic (n=654), and further assessed in a Caucasian (n=802) and African American (n=298) patient-control series collected through the Ischemic Stroke Genetics Study (ISGS). Results: Sequencing of the 269 SWISS probands identified one (0.4%) with small vessel type stroke carrying a known CADASIL mutation (p.R558C; Exon 11). Of the 19 common NOTCH3 variants identified, the only variant significantly associated with ischemic stroke after multiple testing adjustment was p.R1560P (rs78501403; Exon 25) in the combined SWISS and ISGS Caucasian series (Odds Ratio [OR] 0.50, P=0.0022) where presence of the minor allele was protective against ischemic stroke. Although only significant prior to adjustment for multiple testing, p.T101T (rs3815188; Exon 3) was associated with an increased risk of small-vessel stroke (OR: 1.56, P=0.008) and p.P380P (rs61749020; Exon 7) was associated with decreased risk of large-vessel stroke (OR: 0.35, P=0.047) in Caucasians. No significant associations were observed in the small African American series. Conclusion: Cysteine-affecting NOTCH3 mutations are rare in patients with typical ischemic stroke, however our observation that common NOTCH3 variants may be associated with risk of ischemic stroke warrants further study.pt
dc.language.isoengpt
dc.publisherPublic Library of Sciencept
dc.relationOAR is a recipient of a James and Ester King Foundation New Investigator Award from the Department of Health, Florida State. OAR is also funded by the American Heart Association (AHA) and the Myron and Jane Hanley Award in Stroke Research. The Siblings with Ischemic Stroke Study was funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) (R01 NS39987; JFM, PI) and by a Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine. The Ischemic Stroke Genetics Study (ISGS) was funded by a grant from the NINDS (R01 NS42733). ZKW is partially supported by the National Institutes of Health (NIH) /NINDS P50 NS072187, Mayo Clinic Center for Regenerative Medicine, and Dystonia Medical Research Foundation. This work was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services, project number Z01 AG000950-06; the UK Motor Neurone Disease Association grant 6057 to John Hardy and Richard Orrell and Alzheimer's Research UK funding to John Hardy. This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee and a fellowship from Alzheimer's Research UK to Dr. Guerreiro.pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subject.meshAdultpt
dc.subject.meshAgedpt
dc.subject.meshAged, 80 and overpt
dc.subject.meshBrain Ischemiapt
dc.subject.meshCase-Control Studiespt
dc.subject.meshFemalept
dc.subject.meshGene Frequencypt
dc.subject.meshHumanspt
dc.subject.meshMalept
dc.subject.meshMiddle Agedpt
dc.subject.meshModels, Geneticpt
dc.subject.meshPolymorphism, Single Nucleotidept
dc.subject.meshReceptor, Notch3pt
dc.subject.meshReceptors, Notchpt
dc.subject.meshRisk Factorspt
dc.subject.meshStrokept
dc.subject.meshWhite Peoplept
dc.subject.meshGenetic Predisposition to Diseasept
dc.titleNOTCH3 variants and risk of ischemic strokept
dc.typearticle-
degois.publication.firstPagee75035pt
degois.publication.issue9pt
degois.publication.titlePLoS ONEpt
dc.peerreviewedyespt
dc.identifier.doi10.1371/journal.pone.0075035pt
degois.publication.volume8pt
dc.date.embargo2013-01-01*
uc.date.periodoEmbargo0pt
item.cerifentitytypePublications-
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
NOTCH3-Variants-and-Risk-of-Ischemic-StrokePLoS-ONE.pdf391.81 kBAdobe PDFView/Open
Show simple item record

Page view(s)

65
checked on May 15, 2024

Download(s)

10
checked on May 15, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons